|
gptkbp:instance_of
|
gptkb:drug
|
|
gptkbp:bfsLayer
|
6
|
|
gptkbp:bfsParent
|
gptkb:bimatoprost
gptkb:Xalatan_eye_drops
|
|
gptkbp:activities
|
increases aqueous humor outflow
|
|
gptkbp:appointed_by
|
gptkb:sneaker
|
|
gptkbp:brand
|
gptkb:Xalatan
|
|
gptkbp:class
|
prostaglandin analog
|
|
gptkbp:clinical_trial
|
Phase III
treatment of elevated intraocular pressure
|
|
gptkbp:contraindication
|
hypersensitivity to latanoprost
active intraocular inflammation
|
|
gptkbp:developed_by
|
gptkb:Pharmacia
|
|
gptkbp:dosage_form
|
gptkb:software_framework
1 drop in affected eye(s) once daily
|
|
gptkbp:duration
|
long-term
|
|
gptkbp:formulation
|
0.005% solution
|
|
gptkbp:has_ability
|
0.005%
|
|
gptkbp:healthcare
|
gptkb:2001
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
latanoprost
|
|
gptkbp:indication
|
gptkb:ocular_hypertension
|
|
gptkbp:ingredients
|
gptkb:latanoprost
C20 H27 O4
|
|
gptkbp:interacts_with
|
may interact with other eye medications
|
|
gptkbp:is_atype_of
|
S01 E E01
|
|
gptkbp:is_available_on
|
generic medication
|
|
gptkbp:is_monitored_by
|
intraocular pressure
|
|
gptkbp:is_used_for
|
gptkb:sneaker
|
|
gptkbp:issues
|
do not mix with other medications in the same container
|
|
gptkbp:lifespan
|
17 minutes
|
|
gptkbp:manager
|
topical
|
|
gptkbp:marketed_as
|
many countries
|
|
gptkbp:packaging
|
gptkb:beer
|
|
gptkbp:pharmacokinetics
|
lowers intraocular pressure
metabolized to latanoprost acid
|
|
gptkbp:requires
|
gptkb:theorem
|
|
gptkbp:rounds
|
renal
|
|
gptkbp:safety_features
|
Category C
|
|
gptkbp:scholarships
|
avoid contact with soft contact lenses
|
|
gptkbp:shelf_life
|
2 years
|
|
gptkbp:side_effect
|
eye irritation
conjunctival hyperemia
eyelash growth
increased brown pigmentation of the iris
|
|
gptkbp:storage
|
room temperature
|
|
gptkbp:suitable_for
|
pregnant women
breastfeeding women
|
|
gptkbp:traded_on
|
gptkb:Xalatan
|
|
gptkbp:treatment
|
gptkb:open-angle_glaucoma
|